Authorization

Alnylam Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates

(RTTNews) - Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):

-Earnings: -$179.23 million in Q2 vs. -$219.48 million in the same period last year.
-EPS: -$1.56 in Q2 vs. -$2.02 in the same period last year.
-Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of -$191.33 million or -$1.67 per share for the period.
-Analysts projected -$1.74 per share
-Revenue: $103.96 million in Q2 vs. $44.71 million in the same period last year.

-Guidance:
Full year revenue guidance: $280 - $300 Mln
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Сентябрь 2020    »
ПнВтСрЧтПтСбВс
 123456
78910111213
14151617181920
21222324252627
282930